Cargando…

The Emerging Role of Irisin in Cardiovascular Diseases

Irisin, a novel hormone like polypeptide, is cleaved and secreted by an unknown protease from a membrane‐spanning protein, FNDC5 (fibronectin type III domain‐containing protein 5). The current knowledge on the biological functions of irisin includes browning white adipose tissue, regulating insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jinjuan, Li, Fangtang, Tang, Yuanjuan, Cai, Lin, Zeng, Chunyu, Yang, Yongjian, Yang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751904/ https://www.ncbi.nlm.nih.gov/pubmed/34622672 http://dx.doi.org/10.1161/JAHA.121.022453

Ejemplares similares

Gastrointestinal–Renal Axis: Role in the Regulation of Blood Pressure
por: Yang, Jian, et al.
Publicado: (2017)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015)

The Role of Social Determinants of Health in Cardiovascular Diseases: An Umbrella Review
por: Teshale, Achamyeleh Birhanu, et al.
Publicado: (2023)

G Protein–Coupled Receptor Kinases: Crucial Regulators of Blood Pressure
por: Yang, Jian, et al.
Publicado: (2016)

Role of Semaphorin Signaling During Cardiovascular Development
por: Sun, Qianchuang, et al.
Publicado: (2018)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair
por: Gartz, Melanie, et al.
Publicado: (2018)

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
por: Belzile‐Dugas, Eve, et al.
Publicado: (2021)

Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
por: Velarde, Gladys, et al.
Publicado: (2023)

Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)

Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease
por: Lui, George K., et al.
Publicado: (2014)

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
por: Eapen, Zubin J., et al.
Publicado: (2016)

Artificial Intelligence: Practical Primer for Clinical Research in Cardiovascular Disease
por: Kagiyama, Nobuyuki, et al.
Publicado: (2019)

Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement
por: Bhugra, Priyanka, et al.
Publicado: (2021)

Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease
por: O'Gallagher, Kevin, et al.
Publicado: (2022)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease
por: Wang, Juan, et al.
Publicado: (2019)

COVID‐19, Social Determinants of Health, and Opportunities for Preventing Cardiovascular Disease: A Conceptual Framework
por: Russo, Rienna G., et al.
Publicado: (2021)

Cumulative Lifetime Burden of Cardiovascular Disease From Early Exposure to Air Pollution
por: Kim, Juyong Brian, et al.
Publicado: (2020)

Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
por: Volgman, Annabelle Santos, et al.
Publicado: (2019)

Epicardial and Perivascular Adipose Tissues and Their Influence on Cardiovascular Disease: Basic Mechanisms and Clinical Associations
por: Fitzgibbons, Timothy P., et al.
Publicado: (2014)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Barriers, Opportunities, and Challenges in Addressing Disparities in Diet‐Related Cardiovascular Disease in the United States
por: Kris‐Etherton, Penny M., et al.
Publicado: (2020)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Racial Disparities in Ion Channelopathies and Inherited Cardiovascular Diseases Associated With Sudden Cardiac Death
por: Chahine, Mohamed, et al.
Publicado: (2022)

Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
por: Larson, Anthony S., et al.
Publicado: (2020)

Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity
por: Michos, Erin D., et al.
Publicado: (2023)

Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
por: Lteif, Christelle, et al.
Publicado: (2021)

Treatment, Behavioral, and Psychosocial Components of Cardiovascular Disease Risk Among Survivors of Childhood and Young Adult Cancer
por: Berkman, Amy M., et al.
Publicado: (2015)

Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy
por: Tietjens, Jeremy R., et al.
Publicado: (2018)

American‐Style Football and Cardiovascular Health
por: Kim, Jonathan H., et al.
Publicado: (2018)

Impact of Electronic Cigarettes on the Cardiovascular System
por: Qasim, Hanan, et al.
Publicado: (2017)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Cardiovascular Safety Assessment in Cancer Drug Development
por: Oren, Ohad, et al.
Publicado: (2021)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
por: Wilkinson, Michael J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ks1m1mohh2u9dpvq56q7flfks